España - Medicamentos diversos - PNSP 2024-3-12

different companies won its awards

50

of the awards went to the three most frequent winners

10%

of its calls state an estimated value

59%

Based on 52 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

7.5

of those lots received a single tender

5%

of the awards went to companies based in another country

0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Spain · Medical equipment & pharmaceuticals

different companies won awards here

4,404

of the awards went to the three most frequent winners

4%

winners of the last 12 months were new here

3,848 of 4,119

buyers awarded contracts here

1,005

Based on 15,445 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)

3.8

of those lots received a single tender

41%

of the awards went to companies based in another country

1%

of the tenders came from another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.